These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32933920)

  • 1. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M
    Cacciapaglia F; Manfredi A; Erre G; Piga M; Sakellariou G; Viapiana O; Gremese E; Spinelli FR; Atzeni F; Bartoloni E
    Ann Rheum Dis; 2023 Jul; 82(7):e159. PubMed ID: 32933920
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Gianfrancesco M; Hyrich KL; Yazdany J; Machado PM; Robinson PC
    Ann Rheum Dis; 2022 Oct; 81(10):e191. PubMed ID: 32796043
    [No Abstract]   [Full Text] [Related]  

  • 3. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Giollo A; Bertoldo E; Adami G; Cybulski AJ; Fassio A; Orsolini G; Idolazzi L; Gatti D; Viapiana O; Rossini M
    Ann Rheum Dis; 2022 Nov; 81(11):e222. PubMed ID: 32895237
    [No Abstract]   [Full Text] [Related]  

  • 4. Correspondence to: 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Flood RM; Conway R; Kirby C; Gheta D; Kane DJ; Mullan RH
    Ann Rheum Dis; 2023 Jun; 82(6):e140. PubMed ID: 32816697
    [No Abstract]   [Full Text] [Related]  

  • 5. Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Hyrich KL; Gianfrancesco M; Machado PM; Yazdany J; Robinson PC
    Ann Rheum Dis; 2022 Nov; 81(11):e223. PubMed ID: 32895239
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M
    Andreica I; Kiefer D; Rezniczek GA; Jast R; Buehring B; Kiltz U; Baraliakos X; Braun J
    Ann Rheum Dis; 2022 Oct; 81(10):e189. PubMed ID: 32732243
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on: 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Karahan S; Cetinkaya A; Aydin K; Aslan Sirakaya H
    Ann Rheum Dis; 2023 Mar; 82(3):e75. PubMed ID: 32719043
    [No Abstract]   [Full Text] [Related]  

  • 8. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Khan A; Cole A; Bhadauria N; El-Hassan M; Abdulla D; Axon T; Fattah Z; Manson JJ; Moreno-Cuesta J; Mukerjee D
    Ann Rheum Dis; 2022 Oct; 81(10):e188. PubMed ID: 32732244
    [No Abstract]   [Full Text] [Related]  

  • 9. Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry'.
    Rosenbaum JT; Weisman MH; Shafer C; Aslanyan E; Howard RA; Ogle K; Hamilton H; Reveille JD; Winthrop KL; Choi D
    Ann Rheum Dis; 2023 Jun; 82(6):e138. PubMed ID: 33985940
    [No Abstract]   [Full Text] [Related]  

  • 10. Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry'.
    Mulhearn B
    Ann Rheum Dis; 2023 May; 82(5):e115. PubMed ID: 33648958
    [No Abstract]   [Full Text] [Related]  

  • 11. Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry'.
    Arnaud L; Devilliers H
    Ann Rheum Dis; 2023 May; 82(5):e113. PubMed ID: 33602796
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry' by Arnaud and Devilliers.
    Machado PM; Schäfer M; Strangfeld A; Gossec L; Gianfrancesco M; Lawson-Tovey S; Mateus EF; Carmona L; Hyrich KL; Robinson PC; Yazdany J
    Ann Rheum Dis; 2023 May; 82(5):e114. PubMed ID: 33602795
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Rosenbaum
    Hyrich KL; Schäfer M; Strangfeld A; Carmona L; Gossec L; Mateus EF; Lawson-Tovey S; Gianfrancesco M; Robinson PC; Yazdany J; Machado PM
    Ann Rheum Dis; 2023 Jun; 82(6):e139. PubMed ID: 33985941
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Mulhearn
    Schäfer M; Strangfeld A; Hyrich KL; Carmona L; Gianfrancesco M; Lawson-Tovey S; Mateus EF; Gossec L; Robinson PC; Yazdany J; Machado PM
    Ann Rheum Dis; 2023 May; 82(5):e116. PubMed ID: 33648957
    [No Abstract]   [Full Text] [Related]  

  • 15. Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance physician registry" by Sparks
    Gremese E; Ferraccioli G
    Ann Rheum Dis; 2023 Jul; 82(7):e157. PubMed ID: 34426399
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID-19 Global Rheumatology Alliance (C19-GRA) physician registry.
    Abutiban F; Saleh K; Hayat S; Tarakmah H; Al-Herz A; Ghanem A
    Int J Rheum Dis; 2022 Jul; 25(7):743-754. PubMed ID: 35543332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry.
    Gianfrancesco MA; Leykina LA; Izadi Z; Taylor T; Sparks JA; Harrison C; Trupin L; Rush S; Schmajuk G; Katz P; Jacobsohn L; Hsu TY; D'Silva KM; Serling-Boyd N; Wallwork R; Todd DJ; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Machado PM; Robinson PC; Yazdany J;
    Arthritis Rheumatol; 2021 Mar; 73(3):374-380. PubMed ID: 33146001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry.
    Kihara M; Sugihara T; Asano J; Sato M; Kaneko H; Muraoka S; Ohshima S; Nanki T
    Clin Rheumatol; 2022 Dec; 41(12):3661-3673. PubMed ID: 35974224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance physician registry".
    van Vollenhoven RF; Tas SW; Nurmohamed MT
    Ann Rheum Dis; 2023 Aug; 82(8):e177. PubMed ID: 34389606
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to: Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance physician registry" by Sparks
    Wallace ZS; Sparks JA; Robinson PC; Machado PM; Yazdany J
    Ann Rheum Dis; 2023 Jul; 82(7):e158. PubMed ID: 34426400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.